EDGE
  • home.svg
    Home
  • news.svg
    All updates
  • news.svg
    EDGE Insights
  • list.svg
    Industries
  • db-search.svg
    Company Search
  • company-list.svg
    My Watchlists (Beta)
All Updates

All Updates

icon
Filter
Partnerships
Evolva partners with LEHVOSS for European distribution of Veri-teTM Resveratrol
Alternative Ingredients
Sep 28, 2023
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
‧
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
‧
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Alternative Ingredients

Alternative Ingredients

View industry hub
Sep 28, 2023

Evolva partners with LEHVOSS for European distribution of Veri-teTM Resveratrol

Partnerships

  • Evolva, a Swiss-based producer of natural flavors and fragrances through precision fermentation, has partnered with LEHVOSS UK, a leading European distributor of premium ingredients, to distribute Evolva's Veri-teTM Resveratrol in over a dozen European countries for use in dietary supplements.

  • The company expects this agreement to generate approximately CHF 1.5 million (~USD 1.7 million) in revenue by the end of 2025.

  • Analyst QuickTake: Following the successful market launch of Veri-teTM Resveratrol for use in food and dietary supplements in five Southeast Asian countries (including Thailand and Taiwan ) as well as Brazil , Evolva is now looking to strengthen its distribution in key European countries. Veri-teTM Resveratrol is the main pillar of the company's Health Ingredients (HI) business and contributed 14% YoY HI sales growth in 1H 2023 .

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.